Terms: = Leukemia AND NUTM1, NUT, 256646, ENSG00000184507 AND Treatment
8 results:
1. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
[TBL] [Abstract] [Full Text] [Related]
2. Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification.
Schwab CJ; Murdy D; Butler E; Enshaei A; Winterman E; Cranston RE; Ryan S; Barretta E; Hawking Z; Murray J; Antony G; Vora A; Moorman AV; Harrison CJ
Br J Haematol; 2022 Feb; 196(3):753-763. PubMed ID: 34676543
[TBL] [Abstract] [Full Text] [Related]
3. Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
Li J; Dai Y; Wu L; Zhang M; Ouyang W; Huang J; Chen S
Front Med; 2021 Jun; 15(3):347-371. PubMed ID: 33400146
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological Findings of Haematological Malignancies in Hospital Admitted Patients.
Islam AS; Ara ZG; Bhuiyan GR; Khan AU; Khan MM
Mymensingh Med J; 2021 Jan; 30(1):28-34. PubMed ID: 33397847
[TBL] [Abstract] [Full Text] [Related]
5. How advanced are we in targeting novel subtypes of ALL?
Mullighan CG
Best Pract Res Clin Haematol; 2019 Dec; 32(4):101095. PubMed ID: 31779973
[TBL] [Abstract] [Full Text] [Related]
6. BET bromodomain proteins are required for glioblastoma cell proliferation.
Pastori C; Daniel M; Penas C; Volmar CH; Johnstone AL; Brothers SP; Graham RM; Allen B; Sarkaria JN; Komotar RJ; Wahlestedt C; Ayad NG
Epigenetics; 2014 Apr; 9(4):611-20. PubMed ID: 24496381
[TBL] [Abstract] [Full Text] [Related]
7. Isolation and characterization of an anticancer catechol compound from Semecarpus anacardium.
Nair PK; Melnick SJ; Wnuk SF; Rapp M; Escalon E; Ramachandran C
J Ethnopharmacol; 2009 Apr; 122(3):450-6. PubMed ID: 19429311
[TBL] [Abstract] [Full Text] [Related]
8. Cytotoxic effect of root extract of Tiliacora racemosa and oil of Semecarpus anacardium nut in human tumour cells.
Chakraborty S; Roy M; Taraphdar AK; Bhattacharya RK
Phytother Res; 2004 Aug; 18(8):595-600. PubMed ID: 15476314
[TBL] [Abstract] [Full Text] [Related]
